DJIA 17,334.38 -344.32 -1.95%
NASDAQ 4,689.40 -82.37 -1.73%
S&P 500 2,028.72 -28.37 -1.38%
market minute promo

24.90 -0.04 (-0.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AEGR $24.90 -0.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.61
Previous Close $24.94
Daily Range $24.50 - $25.14
52-Week Range $19.10 - $68.76
Market Cap $708.1M
P/E Ratio -16.19
Dividend (Yield) $0.00 (0.0%)
Volume 107,654
Average Daily Volume 735,598
Current FY EPS -$1.09





Aegerion Pharmaceuticals, Inc. (AEGR) Description

Aegerion Pharmaceuticals, Inc. Website:

News & Commentary Rss Feed

Buying These 3 Stocks Is Like Making a Bet in a Burning House

Aegerion Pharmaceuticals, MannKind Corp., and VIVUS, Inc. have all attracted short sellers in droves this year. With each company facing serious headwinds, should investors avoid these struggling biotechs?

Perilous Reversal Stock: Aegerion Pharmaceuticals (AEGR)

Report: Holders Push For Sale At Aegerion Pharmaceuticals

Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog

Aegerion Target of SEC Probe Related to Drug Sales Practices

Big Short Interest On These 5 Biotech Stocks

A Tale of Two Rare Disease Stocks: NPS Pharma Bought for $5.2B, Aegerion Struggles Alone.

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Why Is George Soros Buying This Beaten Down Biotech Stock?

Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?

11.1% of XBI Holdings Seeing Recent Insider Buys

See More AEGR News...

AEGR's Top Competitors

AEGR $24.90 (-0.16%)
Current stock: AEGR
JNJ $101.25 (-0.99%)
Current stock: JNJ
NVS $98.35 (1.93%)
Current stock: NVS
RHHBY $35.54 (0.17%)
Current stock: RHHBY